July 10, 2007 – The Joint Department of Medical Imaging of the University Health Network (UHN) / Mount Sinai Hospital (MSH) / Women’s College Hospital (WCH), based in Toronto, Ontario, Canada, selected Medrad Inc. as its contract supplier partner for Vascular Injection Systems used in computed tomography (CT), magnetic resonance (MR) and cardiovascular imaging procedures and for MR Patient Monitoring Systems as these facilities strive to enhance cardiac imaging and patient care services.
Among the products included in the agreement are the Stellant Dual CT Injection System, which enables simultaneous injection of contrast and saline for improved cardiac CT imaging, and the Veris MR Patient Monitor that allows clinicians to monitor patient vital signs during MR imaging. Together with Certo MR Wireless Network, Veris can promote more efficient and attentive patient care by permitting continuous, remote monitoring of multiple patients in preparation rooms and post-procedure recovery areas.
Scott Jarrett, senior director at the Joint Department of Medical Imaging, said, “This agreement with Medrad lets us standardize products across our facilities with obvious benefits for patient safety and quality. We’re also happy to have a partner for wireless networking that will keep mission critical medical devices operational.”
Medrad will also supply power injection systems for MR, the Spectris Solaris EP MR Injection System and for cardiovascular applications, the MEDRAD Avanta Fluid Management Injection System. It will also supply the Vanguard Dx Angiographic Catheter line.
For more information: www.medrad.com.
January 11, 2024 
